CNS tumor test kit NEUROCAN™

oncologyfor precision medicineFFPE tissues

Primary central nervous system (CNS) tumors are a group of tumor types originating from the brain or spinal cord tissue, and can be differentiated from metastatic brain tumors that spread to the brain from a tumor developed in another part of the body. Although certain genetic syndromes may increase the risk of developing CNS tumors, the causes of most adult primary CNS tumors are still unknown. CNS tumors can be benign or malignant. Current standard treatment options consist of surgery, radiation therapy and chemotherapy. Recent genome-wide studies of malignant CNS tumors have unveiled molecular biomarkers that may influence clinical treatment decision-making – some of which have been incorporated by the World Health Organization (WHO) into Classification of Tumors of the Central Nervous System in 2016. These tumors were classified based on both histological appearance and molecular parameters. Targets 106 key genes in central nervous system tumors  Facilitates CNS tumor classification and grading Utilizes associated genetic biomarkers to predict efficacy and toxicity of chemotherapy Assesses genetic predisposition to CNS tumors Optional MGMT promoter methylation test WHO IS IT FOR Patients with central nervous system tumors seeking precision medicine Individual with family history of familial CNS tumor syndromes SAMPLE TYPES Tumor tissue (FFPE block/slides, or frozen tissue) Fine needle biopsy